You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Evaluation of risk factors for ofloxacin – resistant infections in urinary tract infections
- In: Hospital Pharmacy - Posters
- At: Istanbul (Turkey) (2009)
- Type: Poster
- Poster code: HPS-P-074
- By: ACIU, Mariana (University of Medicine and Pharmacy, Craiova, Romania)
- Co-author(s): Calina, Daniela (University of Medicine and Pharmacy, CRAIOVA, Romania)
Chiutu, Luminita (University of Medicine and Pharmacy, CRAIOVA, Romania)
Mitrut, Paul (University of Medicine and Pharmacy, CRAIOVA, Romania)
Georgescu, Cristian (University of Medicine and Pharmacy, CRAIOVA, Romania)
Calina, Vivi (University of Medicine and Pharmacy, CRAIOVA, Romania) - Abstract:
Objectives: The study was undertaken to assess the safety and efficacy of intravenous Ofloxacin (Tarivid, Avensis Pharma) and oral Ofloxacin (Ofloxacin, Antibiotice Iasi) in the treatment of moderate-to-severe urinary tract infections (UTI), and to identify risk factors for acquiring UTI caused by Ofloxacin - resistant germs.
Materials and.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026